Background/Aims: Previous studies have reported that endotoxemia is associated with pathogenesis and complications in cirrhosis. Endotoxin stimulates the secretion of inflammatory cytokines, which contributes to the development of complications. In addition, endotoxin easily invades the gut barrier system because of the increased intestinal permeability due to portal hypertensive enteropathy. In this report, we explored changes in cytokine levels and intestinal permeability and measured the thickness and elasticity of the bowel wall using ultrasonography in cirrhotic patients. Methods: We enrolled 40 patients with cirrhosis classified as Child-Pugh B or C and 20 healthy volunteers. Abdominal ultrasonography examinations were used to evaluate bowel wall parameters in the ascending colon and terminal ileum. Intestinal permeability was measured using dual sugar absorption tests with lactulose and mannitol. Levels of tumor necrosis factor (TNF)-α and IL-10 were determined from blood samples. We compared these outcomes between cirrhotic patients and healthy controls and between Child-Pugh B and C patients. In addition, we explored the correlation between cytokine levels, intestinal permeability ratio, and bowel wall parameters in cirrhotic patients. Results: In cirrhotic patients, the ascending colon wall elasticity decreased (20.4 vs. 10.9 kPa, p = 0.048) and the terminal ileum wall thickness increased (4.2 vs. 1.9 mm, p < 0.001). The intestinal permeability ratio and levels of the cytokines TNF-α and IL-10 increased (0.219 vs. 0.017, p < 0.001; 22.47 vs. 13.48 pg/mL, p < 0.001; and 14.91 vs. 8.57 pg/mL, p = 0.019, respectively) in cirrhotic patients. However, there were no significant differences between Child-Pugh classes and no significant correlations between bowel wall parameters and intestinal permeability or cytokine levels. Conclusions: Ultrasonography revealed bowel wall thickening and decreases in elasticity; in addition, intestinal permeability and cytokine levels increased in cirrhotic patients compared with healthy controls. (Korean J Med 2019;94:511-518) 
INTRODUCTION
and C-reactive protein [4] . These cytokines contribute to the progression of liver fibrosis and development of cirrhosis complications. Lin et al. [5] reported that endotoxin contributes to compromised immunity in cirrhotic patients through the expression of interleukin (IL)-10 and human leukocyte antigen-DR. Jain et al. [4] also reported elevated endotoxin and TNF levels in patients with hepatic encephalopathy with cirrhosis. These cytokines additionally induce increases in nitric oxide, leading to vasodilation. The hyperdynamic circulatory state due to vasodilation causes other serious complications such as ascites, variceal bleeding, hepatorenal syndrome, and hepatic encephalopathy. Bacteria and endotoxin easily invade the gut barrier in patients with cirrhosis because of increased intestinal permeability due to portal hypertensive enteropathy.
Endotoxemia can increase intestinal permeability, which triggers a vicious cycle [6] .
Bowel wall thickening is a common finding in abdominal computed tomography (CT) scans of patients with cirrhosis [7] .
Gastrointestinal wall thickening can appear in many conditions such as ischemia, inflammation, hemorrhage, or neoplasm; however, in patients with cirrhosis, bowel wall thickening is caused by intestinal edema [8] . Portal hypertension plays an important role in intestinal edema, which in turn causes mucosal disintegrity and increases intestinal permeability [9] . Ultrasonography (US) has several advantages compared to CT, such as wider availability, avoidance of radiation exposure, and the ability to assess the elasticity of the intestine. Several studies have explored bowel elasticity using US elastography in patients with Crohn's disease [10] [11] [12] . These studies showed that bowel elasticity changes according to disease activity. We hypothesized that bowel wall edema and increased permeability would result in changes in bowel elasticity in patients with cirrhosis. To the best of our knowledge, bowel wall changes have not been assessed using US in patients with cirrhosis.
Therefore, we assessed the relationship between intestinal permeability, inflammatory cytokines, and bowel wall changes using US in patients with cirrhosis.
MATERIALS AND METHODS
We prospectively enrolled 40 decompensated cirrhotic patients To explore the correlations between levels of inflammatory cytokines, intestinal permeability ratio, and bowel wall parameters, and between liver elasticity and US findings of the bowel wall, the Spearman's correlation coefficient test was used.
RESULTS
The mean ages of healthy control and cirrhotic patients were Table 1 .
TNF-α levels in cirrhotic patients were significantly higher than in healthy controls (22.47 vs. 13.48 pg/mL, p < 0.001). IL-10 levels also increased in cirrhotic patients compared with healthy controls (14.91 vs. 8.57 pg/mL, p = 0.019) ( Fig. 1 ). However, there were no significant differences between the Child-Pugh B and C groups (TNF-α, 25.44 vs. 19 .51 pg/mL, p = 0.117; IL-10, 16 .56 vs. 13.26 pg/mL, p = 0.549) ( Table 2 ).
The intestinal permeability ratio was significantly higher in cirrhotic patients than in healthy controls (0.219 vs. 0.017, p < 0.001), but there was no significant difference between the Child-Pugh B and C groups (0.181 vs. 0.259, p = 0.158) ( Table 2 ).
The wall of the terminal ileum was significantly thicker in cirrhotic patients compared to healthy controls (4.2 vs. 1.9 mm, p < 0.001). The ascending colon wall was significantly less elastic in cirrhotic patients compared with healthy controls (20.4 vs.
10.9 kPa, p = 0.048) ( Table 3 , Fig. 2 ). There was a significant correlation between terminal ileum wall thickness and liver elasticity (p = 0.028). However, ascending colon wall thickness was not correlated with liver elasticity (p = 0.051). The wall elasticity of the terminal ileum and ascending colon was not correlated with liver elasticity (p = 0.876 and 0.468 for the ascending colon and terminal ileum, respectively). Furthermore, there were no significant relationships between bowel wall thickness or elasticity (terminal ileum or ascending colon) and intestinal permeability or levels of TNF-α and IL-10 (Table 4 ).
Table 4. Coefficients (r) of correlations between bowel wall parameters and levels of inflammatory cytokines and the intestinal permeability (IP) ratio in cirrhotic patients
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DISCUSSION
In our study, intestinal permeability increased in cirrhotic patients compared with healthy controls. However, there was no association between disease severity and intestinal permeability.
Intestinal permeability is as an indicator of the gut barrier system, and when the gut barrier system is damaged, intestinal permeability increases and toxic materials such as endotoxins can invade the intestines. Previous reports have explored intestinal permeability in cirrhotic patients. Choi et al. [13] reported that intestinal permeability was higher in 27 cirrhotic patients than in the normal population, and intestinal permeability increased proportionally with degree of cirrhosis. Conversely, Benjamin et al. [14] also reported that intestinal permeability was elevated in cirrhotic patients, but the increase in intestinal permeability was not associated with degree of cirrhosis. Increased intestinal permeability is known as leaky gut syndrome [15] . Previous studies have explored therapeutic approaches to treat leaky guts in cirrhotic patients [16, 17] . Antibiotics, probiotics, synbiotics, 
